PALO ALTO, Calif.—SightGlass Vision, a life sciences company focused on ending nearsightedness (myopia), announced on Wednesday that it has achieved Conformite Europeene (CE) Mark declaration on its first product, a novel eyeglass designed to slow the progression of myopia in children. The CE Mark confirms that SightGlass Vision’s Diffusion Optics Technology (DOT) spectacle lens products meet European Union (EU) regulatory standards, and allows the company to commercialize its suite of DOT products across the EU, U.K., and other European Economic Area countries.

Read more